Causes for hospitalization and death in Iranian patients with β-thalassemia major
- PMID: 20795770
- DOI: 10.3109/08880018.2010.503336
Causes for hospitalization and death in Iranian patients with β-thalassemia major
Abstract
There are limited studies that have focused on the causes for hospitalization as an indicator of morbidity in patients with β-thalassemia major (BTM). A cross-sectional study was conducted to determine the main causes for hospitalization and death in hospitalized BTM patients in a referral hospital in Shiraz, southern Iran. During a 5-year period, 555 BTM patients were admitted to the hospital, of which 390 (67.7%) were 10 to 20 years of age. The most frequent causes for hospitalization were splenectomy (23%), heart failure (22.6%), liver biopsy (22.2%), uncontrolled diabetes (10.9%), arrhythmia (7.2%), cholecystectomy (3.8%), hypoparathyroidism (2.1%), and sepsis (2%). Of the hospitalized patients, 65 (11%), with a mean age of 16.1 ± 4.2 years, died. The most common causes of death were cardiomyopathy (72.3%), infections (17%), malignancies (3.1%), and cerebrovascular accidents (3.1%). Survival of our patients was less than in developed countries and cardiac complications were the most common cause of mortality and morbidity in these patients. Regarding the key role of iron chelation in prevention of different complications in BTM, correction of iron chelation regimen should be well considered.
Similar articles
-
Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.Pediatr Blood Cancer. 2009 Dec;53(6):1064-7. doi: 10.1002/pbc.22144. Pediatr Blood Cancer. 2009. PMID: 19533641
-
Survival and complications in thalassemia.Ann N Y Acad Sci. 2005;1054:40-7. doi: 10.1196/annals.1345.006. Ann N Y Acad Sci. 2005. PMID: 16339650 Review.
-
Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.Ann N Y Acad Sci. 2005;1054:445-50. doi: 10.1196/annals.1345.067. Ann N Y Acad Sci. 2005. PMID: 16339695
-
Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:158-69. Pediatr Endocrinol Rev. 2008. PMID: 19337172
-
β-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.Hemoglobin. 2021 Jan;45(1):1-4. doi: 10.1080/03630269.2020.1857266. Epub 2020 Dec 14. Hemoglobin. 2021. PMID: 33317358
Cited by
-
The survival rate of patients with beta-thalassemia major and intermedia and its trends in recent years in Iran.Epidemiol Health. 2018;40:e2018048. doi: 10.4178/epih.e2018048. Epub 2018 Oct 3. Epidemiol Health. 2018. PMID: 30336663 Free PMC article.
-
Experience of Uncertainty in Patients with Thalassemia Major: A Qualitative Study.Int J Hematol Oncol Stem Cell Res. 2020 Oct 1;14(4):237-247. doi: 10.18502/ijhoscr.v14i4.4479. Int J Hematol Oncol Stem Cell Res. 2020. PMID: 33603985 Free PMC article.
-
Major causes of hospital admission in Beta thalassemia major patients in southern iran.Iran J Pediatr. 2011 Dec;21(4):509-13. Iran J Pediatr. 2011. PMID: 23056840 Free PMC article.
-
Evaluation and cost analysis of national health policy of thalassaemia screening in west-azerbaijan province of iran.Int J Prev Med. 2012 Oct;3(10):687-92. Int J Prev Med. 2012. PMID: 23112894 Free PMC article.
-
Prevalence of Hepatitis C among Multi-transfused Thalassaemic Patients in Oman: Single centre experience.Sultan Qaboos Univ Med J. 2015 Feb;15(1):e46-51. Epub 2015 Jan 21. Sultan Qaboos Univ Med J. 2015. PMID: 25685385 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical